Senores Pharma acquires 14 ANDAs from Dr. Reddy’s
The basket acquired comprises 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s Laboratories
USFDA classifies inspection at Dr Reddy’s API facility as Voluntary Action Indicated
Dr Reddy’s Laboratories receives Establishment Inspection Report for its API manufacturing facility in Bollaram, Hyderabad
Indian pharma companies focus on innovative research in foreign countries through dedicated entities
According to GlobalData’s Pharmaceutical Intelligence Center, as of 20 December 2024, there are a total of 16 drugs in the…
Eco-conscious packaging: A strategic opportunity
Larger pharma companies are applying sustainable practices and eco-conscious materials to packaging and labelling, leading to…
Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in…
Dr. Reddy's Laboratories, in collaboration with Shanghai Junshi Biosciences has recently launched checkpoint inhibitor Zytorvi…
Dr. Reddy’s launches Toripalimab under the brand name Zytorvi in India
Toripalimab is an immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
17th CPHI & PMEC India Expo to highlight advancements in pharma industry
Event to focus on innovation, sustainability, and India’s growing role in the global pharma sector
Biocon and Dr Reddy’s featured in Science Magazine’s Top Employers List
This year’s ranking is based on a comprehensive web-based survey of about 6,400 respondents
Dr Reddy’s launches BixiBat to treat chronic constipation in India
Elobixibat was approved by the CDSCO after submission of the company's successful Phase-3 clinical trial to the Subject Expert…
Dr Reddy’s Laboratories among top 15 biotech and pharma employers in Science Magazine Survey
Company ranks high for employee respect, loyalty, and social responsibility in Science magazine’s 2024 survey